Steven C. Mayer
Gründer bei Teva Biopharmaceuticals USA, Inc.
Profil
Steven C.
Mayer is the founder and the Chief Executive Officer & Director of Teva Biopharmaceuticals USA, Inc. since 2005.
He is currently the Treasurer & Director at the Foundation for the National Institutes of Health, Inc. since 2015.
Previously, he held the position of Chief Financial Officer & Executive Vice President at Human Genome Sciences, Inc. He was also the Chief Financial Officer & Senior Vice President at TheraTech, Inc. from 1991 to 1995.
Additionally, he served as the Chief Financial Officer & Vice President at GenVec, Inc. from 1995 to 1996.
Mr. Mayer was a Principal at Myriad Genetics, Inc. and Martin Marietta Corp.
He holds an MBA from Stanford University and an undergraduate degree from Williams College.
Aktive Positionen von Steven C. Mayer
| Unternehmen | Position | Beginn |
|---|---|---|
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Gründer | 21.07.2009 |
Foundation for the National Institutes of Health, Inc.
 Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Foundation for the National Institutes of Health, Inc. provides healthcare services. It offers services to public health through scientific discovery, translational research and dissemination of research results through public-private partnerships. The organization was founded in 1996 and is headquartered in Bethesda, MD | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Steven C. Mayer
| Unternehmen | Position | Ende |
|---|---|---|
| GENVEC INC | Finanzdirektor/CFO | 01.01.1996 |
TheraTech, Inc.
 TheraTech, Inc. Medical DistributorsDistribution Services TheraTech, Inc. manufactures and distributes medical devices. The company was founded by Chick Sanford & Dinesh C. Patel in January, 1985 and is located in Hopkins, MN | Finanzdirektor/CFO | 01.01.1995 |
| Martin Marietta Corp. | Corporate Officer/Principal | - |
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Finanzdirektor/CFO | - |
Ausbildung von Steven C. Mayer
| Stanford University | Masters Business Admin |
| Williams College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MYRIAD GENETICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
TheraTech, Inc.
TheraTech, Inc. Medical DistributorsDistribution Services TheraTech, Inc. manufactures and distributes medical devices. The company was founded by Chick Sanford & Dinesh C. Patel in January, 1985 and is located in Hopkins, MN | Distribution Services |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Health Technology |
| Martin Marietta Corp. | Electronic Technology |
Foundation for the National Institutes of Health, Inc.
Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Foundation for the National Institutes of Health, Inc. provides healthcare services. It offers services to public health through scientific discovery, translational research and dissemination of research results through public-private partnerships. The organization was founded in 1996 and is headquartered in Bethesda, MD | Commercial Services |
